Comparison Of Clinical And Radiological Success Of Pulpotomy Treatments Performed With Proroot MTA, NeoPUTTY MTA, TheraCal PT In Primary Teeth

NCT07260357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-12-03

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to compare clinical and radiological success rates of NeoPutty MTA, ProRoot MTA and TheraCal PT pulpotomy in 4-10 years old healthy pediatric patients. The main question it aims to answer is:

Which of these 3 materials are best suited for pulpotomy treatment in the aspect of clinical and radiological success rates.

Participants will undergo a pulpotomy treatment in primary molar teeth with one of these materials used.

Conditions

  • Dentin Caries

Interventions

OTHER

ProRoot MTA Pulpotomy

Teeth were pulpotomized with Pro-Root MTA in this group.

OTHER

NeoPUTTY MTA Pulpotomy

Teeth were pulpotomized with Neo-Putty MTA in this group.

OTHER

TheraCal PT Pulpotomy

Teeth were pulpotomized with Theracal PT in this group.

Sponsors & Collaborators

  • necmettin erbakan university Scientific Research Projects (BAP)

    collaborator UNKNOWN
  • Necmettin Erbakan University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-10-01
Completion
2024-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07260357 on ClinicalTrials.gov